Taiwan - Delayed Quote TWD

Excelsior Medical Co., Ltd. (4104.TW)

Compare
86.70 0.00 (0.00%)
At close: November 29 at 1:30 PM GMT+8
Loading Chart for 4104.TW
DELL
  • Previous Close 86.70
  • Open 86.70
  • Bid 86.60 x --
  • Ask 86.70 x --
  • Day's Range 86.40 - 86.90
  • 52 Week Range 80.67 - 93.52
  • Volume 47,494
  • Avg. Volume 74,404
  • Market Cap (intraday) 14.167B
  • Beta (5Y Monthly) 0.13
  • PE Ratio (TTM) 18.53
  • EPS (TTM) 4.68
  • Earnings Date --
  • Forward Dividend & Yield 3.62 (4.20%)
  • Ex-Dividend Date Apr 19, 2024
  • 1y Target Est 85.71

Excelsior Medical Co., Ltd. sells medical supplies and equipment, medicines, and home medical devices in Taiwan, Hong Kong, the Philippines, and Malaysia. The company offers equipment for hemodialysis/plasma exchange; blood bag; artificial stoma; scar care products; and health appliances. It engages in the investment, real estate, and leasing businesses, as well as selling of precision instrument. Excelsior Medical Co., Ltd. was incorporated in 1988 and is based in New Taipei City, Taiwan.

www.excelsiormedical.com.tw

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 4104.TW

View More

Performance Overview: 4104.TW

Trailing total returns as of 11/29/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

4104.TW
7.29%
TSEC CAPITALIZATION WEIGHTED ST
24.16%

1-Year Return

4104.TW
9.02%
TSEC CAPITALIZATION WEIGHTED ST
28.38%

3-Year Return

4104.TW
100.26%
TSEC CAPITALIZATION WEIGHTED ST
28.17%

5-Year Return

4104.TW
139.41%
TSEC CAPITALIZATION WEIGHTED ST
91.64%

Compare To: 4104.TW

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 4104.TW

View More

Valuation Measures

Annual
As of 11/29/2024
  • Market Cap

    14.17B

  • Enterprise Value

    8.88B

  • Trailing P/E

    18.52

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.68

  • Price/Book (mrq)

    1.61

  • Enterprise Value/Revenue

    1.05

  • Enterprise Value/EBITDA

    6.12

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    9.25%

  • Return on Assets (ttm)

    2.49%

  • Return on Equity (ttm)

    8.88%

  • Revenue (ttm)

    8.41B

  • Net Income Avi to Common (ttm)

    777.26M

  • Diluted EPS (ttm)

    4.68

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    3.27B

  • Total Debt/Equity (mrq)

    13.79%

  • Levered Free Cash Flow (ttm)

    -126.91M

Research Analysis: 4104.TW

View More

Company Insights: 4104.TW

Research Reports: 4104.TW

View More

People Also Watch